Developing innovative treatments for genitourinary tract disorders
Ixaltis has raised €11M across 2 funding rounds from 4 investors, most recently a Debt round in May 2016. Based in Archamps, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2016-05-01 | Debt | €2.8M | — | View deal → |
| 2016-05-01 | Series A | €8.0M | IRDInov,iXO Private Equity,Principia SGR,Sofimac Partners | View deal → |
